Eversept Partners’s Oscar Health OSCR Stock Holding History

Eversept Partners’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-310,893	Closed	-$4.92M	–	78
2024 Q2	$4.92M	Buy	+310,893	New	+$5.71M	0.34%	44

Other funds holding OSCR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Eversept Partners's OSCR Position: Q3 2024 in Review

Eversept Partners sold out of Oscar Health (OSCR) in Q3 2024, closing a stake of 310,893 shares — an estimated $4.92M sold.

Eversept Partners first reported a position in OSCR in Q2 2024 and held it in 1 quarter. The position peaked at $4.92M in Q2 2024. 284 funds tracked by Wall St. Rank hold OSCR as of Q3 2024.

Eversept Partners reported no remaining Oscar Health position as of Q3 2024 after selling out during the quarter.
Eversept Partners sold 310,893 Oscar Health shares in Q3 2024, an estimated $4.92M.
Eversept Partners first reported a position in Oscar Health in Q2 2024 and held it in 1 quarter.
Eversept Partners's Oscar Health position peaked at $4.92M in Q2 2024.
284 funds tracked by Wall St. Rank held Oscar Health as of Q3 2024.

Based on Eversept Partners's 13F filing for Q3 2024, filed 14 Nov 2024.